Cargando…
An unusual response to 5‐azacitidine by a patient with chronic myelomonocytic leukemia
KEY CLINICAL MESSAGE: Hypomethylating agents may be useful in some but not all cases of myelodysplastic syndromes. In some versions of these conditions, this treatment may yield deleterious results. ABSTRACT: Chronic myelomonocytic leukemia (CMML) is considered to be a heterogeneous group of hematop...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397479/ https://www.ncbi.nlm.nih.gov/pubmed/37546162 http://dx.doi.org/10.1002/ccr3.7748 |